Skip to main content

Animations

MJFF Publications

1511 - 1520 of 8801 Results
Title
Year
  • Year
  • 2024
  • 2022
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • 2024
  • 2024
  • 2021
  • Summary Details
    OPEN
    Title: Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2024.1349030
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Atypical antipsychotic use and mortality risk in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.013
    Citation Count: 7
  • Summary Details
    OPEN
    Title: An open-source MRI compatible frame for multimodal presurgical mapping in macaque and capuchin monkeys
    Journal Name: Journal of Neuroscience Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by
    DOI - Digital Object Identifier: 10.1016/j.jneumeth.2024.110133
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Single-cell multiplex chromatin and RNA interactions in ageing human brain
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-024-07239-w
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2318943121
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Role of GBA variants in Lewy body disease neuropathology
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-024-02699-w
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Interaction of an α-synuclein epitope with HLA-DRB1∗15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s disease
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuron.2023.07.015
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1002/dad2.12589
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Lysosomal genes contribute to Parkinson’s disease near agriculture with high intensity pesticide use
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00703-4
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-021-02265-x
    Citation Count: 15
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.